Summary & Overview
HCPCS J1160: Digoxin Injection, up to 0.5 mg
HCPCS Level II code J1160 designates the injection of digoxin up to 0.5 mg, a parenteral cardiac glycoside used in specific cardiac conditions. The code identifies a discrete drug administration event and is relevant for billing in outpatient and ambulatory settings where digoxin is provided by injection. Nationally, accurate coding for J1160 supports appropriate drug identification on claims and ensures consistent capture of utilization for cardiac medication administrations.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of payer coverage patterns and benchmarks where available, clinical context around digoxin injection as an administered therapy, and any recent policy or coding considerations impacting claims processing. The publication summarizes typical sites of service and the service type associated with J1160, and flags areas where input data was not provided.
This summary equips billing managers, revenue cycle staff, and clinical administrators with the context needed to recognize HCPCS Level II code J1160 on claims, understand its clinical role, and locate relevant payer policy and benchmarking information in the full report.
Billing Code Overview
HCPCS Level II code J1160 represents an injection of digoxin, up to 0.5 mg. This service is typically an administration of a cardiac glycoside medication used to support cardiac function in select clinical situations.
-
Service type: Medication injection
-
Typical site of service: Ambulatory care settings such as physician offices, outpatient clinics, and hospital outpatient departments where parenteral cardiac medication administration is provided.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with symptomatic atrial fibrillation, supraventricular tachycardia, or congestive heart failure presenting for inpatient or outpatient intravenous rate control or inotropic management. The clinician prepares and administers J1160 (injection, digoxin, up to 0.5 mg) when rapid serum-level achievement is required or when oral therapy is not feasible (for example, NPO status, vomiting, or impaired gastrointestinal absorption). The workflow includes assessment of vital signs, confirmation of current medications and renal function, obtaining baseline serum electrolytes and digoxin level if indicated, calculating dose based on weight and renal function, preparing the dilution per institutional protocol, administering the injection IV push or IV infusion as ordered, monitoring cardiac rhythm and vitals during and after administration, and documenting dose, route, lot number, and patient response in the medical record. Typical sites of service are hospital inpatient units, emergency departments, observation units, and physician offices or infusion clinics capable of cardiac monitoring.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | State-assigned modifier (no special meaning for claims processing) | Rarely used; follow payer instructions when a state-specific modifier is required. |